OCT 10, 2026 · JOURNAL ARTICLE
Non-perforating inflammatory colitis following ramucirumab plus docetaxel therapy in a patient with non-small cell lung cancer: a case report and review of the literature
Journal of Pharmaceutical Health Care and Sciences
Abstract Background Ramucirumab (RAM) plus docetaxel (DTX) therapy is used as a second-line or later treatment for advanced or recurrent non-small cell lung cancer. Although severe